Miguel Fernandez
Chief Tech/Sci/R&D Officer en STADA ARZNEIMITTEL .
Perfil
El Sr. Miguel P. Fernández es Director Técnico de STADA Arzneimittel AG. Anteriormente, el Sr. Fernández fue Vicepresidente de Operaciones en América de Merck & Co., Inc. y Vicepresidente de Operaciones en América de Merck Sharp & Dohme (Europa), Inc. y Jefe Global de Sólidos y Tecnología Especial de Novartis AG. Se licenció en la Universidad de Madrid y se graduó en la Universidad de Madrid.
Cargos activos de Miguel Fernandez
Empresas | Cargo | Inicio |
---|---|---|
STADA ARZNEIMITTEL | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Antiguos cargos conocidos de Miguel Fernandez.
Empresas | Cargo | Fin |
---|---|---|
Merck Sharp & Dohme (Europe), Inc. | Corporate Officer/Principal | - |
MERCK & CO., INC. | Corporate Officer/Principal | - |
NOVARTIS AG | Corporate Officer/Principal | - |
Formación de Miguel Fernandez.
Madrid University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
NOVARTIS AG | Health Technology |
Empresas privadas | 2 |
---|---|
STADA Arzneimittel AG
STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
Merck Sharp & Dohme (Europe), Inc. |
- Bolsa de valores
- Insiders
- Miguel Fernandez